AMBALALSA
NSEAmbalal Sarabhai Enterprises Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹32.56
1.31 (4.19%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹250 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹30.3+7.5%
52W High₹38.5-15.4%
Current Price
₹32.56
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹26.05
Upper Circuit₹39.07
Reference Price
₹32.56
Investment Checklist
Volume divergence: Bullish (price down, volume up)
Trend: Price below most MAs — downtrend
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Composite score -29.69 (SELL) with 72.8% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
73%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend
EMA20
33.52
Price Action
DOWNTREND
BEARISH
Higher Highs3
Higher Lows3
Lower Highs6
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹36.15
₹38.50
Support (Below)
₹30.30
Volume Analysis
TrendSTABLE
Change+5.00%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹32.23
3% Risk₹31.58
5% Risk₹30.93
7% Risk (Custom)
₹30.28Technical Levels
1x ATR (Volatility)₹30.35
2x ATR (Swing)₹28.14
3x ATR (Trend)₹25.93
Immediate Support₹30.30
Financials
Financial data not available
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Latest News
News for AMBALALSA
View AllNEWS
positive
Business Standard - Markets 22d ago
Ambalal Sarabhai Enterprises reports consolidated net profit of Rs 6.50 crore in the March 2026 quarter
Sales rise 1.05% to Rs 65.49 crore
AMBALALSAHealthcare